Hepatitis B and End-Stage Liver Disease

Ilan S. Weisberg, Robert S. Brown, Samuel H. Sigal

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.

Original languageEnglish (US)
Pages (from-to)893-916
Number of pages24
JournalClinics in Liver Disease
Volume11
Issue number4
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

End Stage Liver Disease
Hepatitis B
Fibrosis
Hepatitis B virus
Chronic Hepatitis B
Liver Failure
Chronic Hepatitis
Natural History
Hepatocellular Carcinoma
Therapeutics

ASJC Scopus subject areas

  • Hepatology

Cite this

Hepatitis B and End-Stage Liver Disease. / Weisberg, Ilan S.; Brown, Robert S.; Sigal, Samuel H.

In: Clinics in Liver Disease, Vol. 11, No. 4, 11.2007, p. 893-916.

Research output: Contribution to journalReview article

Weisberg, Ilan S. ; Brown, Robert S. ; Sigal, Samuel H. / Hepatitis B and End-Stage Liver Disease. In: Clinics in Liver Disease. 2007 ; Vol. 11, No. 4. pp. 893-916.
@article{1800ed0367734f3cb9e71b76b7a7335c,
title = "Hepatitis B and End-Stage Liver Disease",
abstract = "Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40{\%} of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.",
author = "Weisberg, {Ilan S.} and Brown, {Robert S.} and Sigal, {Samuel H.}",
year = "2007",
month = "11",
doi = "10.1016/j.cld.2007.08.009",
language = "English (US)",
volume = "11",
pages = "893--916",
journal = "Clinics in Liver Disease",
issn = "1089-3261",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Hepatitis B and End-Stage Liver Disease

AU - Weisberg, Ilan S.

AU - Brown, Robert S.

AU - Sigal, Samuel H.

PY - 2007/11

Y1 - 2007/11

N2 - Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.

AB - Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals. Until recently, the options for a patient who had end-stage hepatitis B cirrhosis were severely limited, but during the past 15 years great strides have been made in prevention and treatment of hepatitis B cirrhosis. This article reviews recent advances in the understanding of the natural history, prevention, and medical management of HBV-related end-stage liver disease.

UR - http://www.scopus.com/inward/record.url?scp=35548946090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548946090&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2007.08.009

DO - 10.1016/j.cld.2007.08.009

M3 - Review article

VL - 11

SP - 893

EP - 916

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

SN - 1089-3261

IS - 4

ER -